Position in ZTS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,324,759
+$5,901 QoQ
Shares Held
78,883
+6.5% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 12%
Shared 0%
None 88%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026MAI Capital Management holds $12,062,659 across 49 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (77.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
78,883 | $9,324,759 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
1,060 | $628,558 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
4,242 | $558,841 | |
| 4 | VTRS |
Viatris Inc
|
31,574 | $426,564 | |
| 5 | HLN |
Haleon plc
|
19,682 | $197,016 | |
| 6 | ANIP |
Ani Pharmaceuticals Inc
|
2,532 | $194,710 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
9,014 | $125,294 | |
| 8 | COLL |
Collegium Pharmaceutical, Inc
|
3,235 | $106,981 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,324,759 | 78,883 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,318,858 | 74,065 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $12,342,677 | 84,354 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $14,595,672 | 93,592 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,594,085 | 100,784 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,787,818 | 103,037 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $21,717,268 | 111,154 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $20,114,094 | 116,025 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $19,723,456 | 116,562 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $18,873,506 | 95,625 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $13,985,904 | 80,388 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,459,150 | 54,928 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $887,957 | 5,335 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $731,870 | 4,994 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $492,174 | 3,319 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $551,595 | 3,209 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $976,896 | 5,180 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $1,705,769 | 6,990 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $923,718 | 4,758 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $868,810 | 4,662 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $710,864 | 4,514 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $680,039 | 4,109 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $618,483 | 3,740 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $608,594 | 4,441 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $515,482 | 4,380 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||